Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares NTRK fusion-positive non-small-cell lung cancer, BRAF V600E-mutant non-small-cell lung cancer, Brain metastases (intracranial disease), Non-small cell lung cancer (KEGG map) and the tags subtype-page, lung.
Shares BRAF V600E-mutant non-small-cell lung cancer, Brain metastases (intracranial disease), Non-small cell lung cancer (KEGG map), MET exon 14 and MET-amplified non-small-cell lung cancer and the tags subtype-page, lung.
Shares BRAF V600E-mutant non-small-cell lung cancer, Non-small cell lung cancer (KEGG map), ALK-positive non-small-cell lung cancer, Pemetrexed and the tags subtype-page, lung.
Shares Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV), ALK-positive non-small-cell lung cancer, Pemetrexed, Roche / Genentech and the tags subtype-page, lung.
Shares ALK-positive non-small-cell lung cancer, Pemetrexed, EGFR-mutated non-small-cell lung cancer, Carboplatin and the tags subtype-page, lung.
Shares Brain metastases (intracranial disease), Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS), Roche / Genentech, Carboplatin and the tags subtype-page, lung.
Shares Carboplatin and the tags subtype-page, lung.
Shares MET exon 14 and MET-amplified non-small-cell lung cancer, ALK-positive non-small-cell lung cancer, MET, Pemetrexed and the tags subtype-page, lung.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.